エストラ−１，３，５（１０），１６−テトラエン−３−カルボキサミド誘導体、それらの製造方法、それらを含む医薬製剤および医薬を製造するためのそれらの使用

摘要

The invention relates to AKR1C3 inhibitors and to processes for their preparation, to their use for the treatment and/or prophylaxis of diseases and also to their use for preparing medicaments for the treatment and/or prophylaxis of diseases, in particular bleeding disorders and endometriosis.